相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dried Blood Spot Real-time Polymerase Chain Reaction Assays to Screen Newborns for Congenital Cytomegalovirus Infection
Suresh B. Boppana et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Neuropathogenesis of Congenital Cytomegalovirus Infection: Disease Mechanisms and Prospects for Intervention
Maxim C. -J. Cheeran et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Towards a Novel Vaccine against Human Cytomegalovirus Based on a Chimeric Ad5F35 Adenovirus Vector Expressing the Immunodominant Antigenic Domain 1 Epitope
Ping Zhao et al.
INTERVIROLOGY (2009)
Ad-gBCMVpoly: A novel chimeric vaccine strategy for human cytomegalovirus-associated diseases
Jie Zhong et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant
Robert F. Pass
JOURNAL OF CLINICAL VIROLOGY (2009)
Essential Role for either TRS1 or IRS1 in Human Cytomegalovirus Replication
Emily E. Marshall et al.
JOURNAL OF VIROLOGY (2009)
One Step Closer to a CMV Vaccine
Cornelia L. Dekker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Vaccine Prevention of Maternal Cytomegalovirus Infection
Robert F. Pass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The beginning of the end of a long wait for a vaccine against cytomegalovirus
P. D. Griffiths
REVIEWS IN MEDICAL VIROLOGY (2009)
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers
David I. Bernstein et al.
VACCINE (2009)
A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain)
Mark A. Jacobson et al.
VACCINE (2009)
The interplay between viruses and innate immune signaling: Recent insights and therapeutic opportunities
Leonie Unterholzner et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Therapeutic and prophylactic applications of alphavirus vectors
Gregory J. Atkins et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
Engineering of cytomegalovirus genomes for recombinant live herpesvirus vaccines
Christian A. Mohr et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Cytomegalovirus strain diversity in seropositive women
Zdenek Novak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
New advances in the diagnosis of congenital cytomegalovirus infection
Tiziana Lazzarotto et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection
Giuseppe Gerna et al.
JOURNAL OF GENERAL VIROLOGY (2008)
A cytomegalovirus vaccine for transplantation: Are we closer?
Vera Go et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects
Mary K. Wloch et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques
Yujuan Yue et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2008)
Induction of Pluripotent Protective Immunity Following Immunisation with a Chimeric Vaccine against Human Cytomegalovirus
Jie Zhong et al.
PLOS ONE (2008)
Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: Scarification vaccination
Garilyn M. Jentarra et al.
VACCINE (2008)
Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection
Xiaohong Cui et al.
VACCINE (2008)
A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector
Z. Wang et al.
VIROLOGY (2008)
Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy
Luka Cicin-Sain et al.
JOURNAL OF VIROLOGY (2007)
Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus
Elizabeth A. Reap et al.
VACCINE (2007)
Incidence of cytomegalovirus infection among the general population and pregnant women in the United States
Fernando A. B. Colugnati et al.
BMC INFECTIOUS DISEASES (2007)
Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
Aileen Kenneson et al.
REVIEWS IN MEDICAL VIROLOGY (2007)
CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects
Stefanie L. Slezak et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1
Zhongde Wang et al.
VACCINE (2007)
New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection
Sheila C. Dollard et al.
REVIEWS IN MEDICAL VIROLOGY (2007)
Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1
Morgan Hakki et al.
JOURNAL OF VIROLOGY (2006)
Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12
MA Jacobson et al.
VACCINE (2006)
A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines
TC Heineman et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 gag coupled to CD8+ T-cell epitopes
Nilu Goonetilleke et al.
JOURNAL OF VIROLOGY (2006)
In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara
C La Rosa et al.
EXPERIMENTAL HEMATOLOGY (2006)
Detection of cytomegalovirus infection during a vaccine clinical trial in healthy young women: Seroconversion and viral shedding
CP Zhang et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection
ZD Wang et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients
MA Jacobson et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism
D Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Washing our hands of the congenital cytomegalovirus disease epidemic
MJ Cannon et al.
BMC PUBLIC HEALTH (2005)
Progress toward an elusive goal: current status of cytomegalovirus vaccines
Mark R. Schleiss et al.
EXPERT REVIEW OF VACCINES (2005)
Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B
WJ Britt et al.
JOURNAL OF VIROLOGY (2005)
The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response
T Brandt et al.
VIROLOGY (2005)
Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells
G Gerna et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Intranasal immunization with a replication-deficient adenovirus vector expressing glycoprotein H of murine cytomegalovirus induces mucosal and systemic immunity
JD Shanley et al.
VACCINE (2005)
Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus
ZD Wang et al.
JOURNAL OF VIROLOGY (2004)
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes
G Hahn et al.
JOURNAL OF VIROLOGY (2004)
Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection
TJ Manley et al.
BLOOD (2004)
Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells
ZD Wang et al.
BLOOD (2004)
Detection of cytomegalovirus infection during clinical trials of glycoprotein B vaccine
CP Zhang et al.
VACCINE (2004)
Vaccine development to prevent cytomegalovirus disease: Report from the National Vaccine Advisory Committee
AM Arvin et al.
CLINICAL INFECTIOUS DISEASES (2004)
Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H
R Elkington et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Functional profiling of a human cytomegalovirus genome
W Dunn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Response to smallpox vaccine in persons immunized in the distant past
SE Frey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunity
JD Shanley et al.
VACCINE (2003)
Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers
R Elkington et al.
JOURNAL OF VIROLOGY (2003)
Maternal immunity and prevention of congenital cytomegalovirus infection
KB Fowler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Herpesvirus genetics has come of age
M Wagner et al.
TRENDS IN MICROBIOLOGY (2002)
Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.
SB Boppana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Encouraging prospects for immunisation against primary cytomegalovirus infection
PD Griffiths et al.
VACCINE (2001)
New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients
IG Sia et al.
CLINICAL MICROBIOLOGY REVIEWS (2000)
分享论文
